Other studies have demonstrated that miR-22 overexpression leads to a reduction of ERα level, at least in part by inducing mRNA degradation, and compromises estrogen signaling, as exemplified by its inhibitory impact on the ERα-dependent proliferation of breast cancer cells [31], [32]. This evidence concerns the gene ESR1 and breast carcinoma.